Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to FOLFIRI
Related studies linked through entity extraction aliases.
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cetuximab Monotherapy Maintenance Treatment in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)
- Status
- COMPLETED
- Phase
- PHASE3
Erbitux MEtastatic Colorectal Cancer Strategy Study
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ABT-165 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Molecularly Tailored Therapy for Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- Status
- COMPLETED
- Phase
- PHASE3